These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 22262216)
1. Radiolabeled glucagon-like peptide-1 analogues: a new pancreatic β-cell imaging agent. Zhang Y; Chen W Nucl Med Commun; 2012 Mar; 33(3):223-7. PubMed ID: 22262216 [TBL] [Abstract][Full Text] [Related]
2. 18F-radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals. Wu H; Liang S; Liu S; Pan Y; Cheng D; Zhang Y Nucl Med Commun; 2013 Jul; 34(7):701-8. PubMed ID: 23652208 [TBL] [Abstract][Full Text] [Related]
3. Development of Kimura H; Matsuda H; Ogawa Y; Fujimoto H; Toyoda K; Fujita N; Arimitsu K; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H Bioorg Med Chem; 2017 Feb; 25(4):1406-1412. PubMed ID: 28089587 [TBL] [Abstract][Full Text] [Related]
4. Preclinical studies of SPECT and PET tracers for NET. Brom M; Boerman O; Gotthardt M; Oyen WJ PET Clin; 2014 Jan; 9(1):63-9. PubMed ID: 25029935 [TBL] [Abstract][Full Text] [Related]
5. Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results. Gotthardt M; Fischer M; Naeher I; Holz JB; Jungclas H; Fritsch HW; Béhé M; Göke B; Joseph K; Behr TM Eur J Nucl Med Mol Imaging; 2002 May; 29(5):597-606. PubMed ID: 11976797 [TBL] [Abstract][Full Text] [Related]
6. [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma. Wicki A; Wild D; Storch D; Seemayer C; Gotthardt M; Behe M; Kneifel S; Mihatsch MJ; Reubi JC; Mäcke HR; Christofori G Clin Cancer Res; 2007 Jun; 13(12):3696-705. PubMed ID: 17575235 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging. Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465 [TBL] [Abstract][Full Text] [Related]
8. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting. Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746 [TBL] [Abstract][Full Text] [Related]
9. GLP-1 and exendin-4 for imaging endocrine pancreas. A review. Labelled glucagon-like peptide-1 analogues: past, present and future. Hubalewska-Dydejczyk A; Sowa-Staszczak A; Tomaszuk M; Stefańska A Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):152-60. PubMed ID: 25719487 [TBL] [Abstract][Full Text] [Related]
10. Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET. Xu Q; Zhu C; Xu Y; Pan D; Liu P; Yang R; Wang L; Chen F; Sun X; Luo S; Yang M J Drug Target; 2015; 23(9):813-20. PubMed ID: 25758750 [TBL] [Abstract][Full Text] [Related]